Aging, cellular senescence, and Alzheimer's disease

RM Liu - International journal of molecular sciences, 2022 - mdpi.com
Aging is the greatest risk factor for late-onset Alzheimer's disease (LOAD), which accounts
for> 95% of Alzheimer's disease (AD) cases. The mechanism underlying the aging-related …

Hemostasis components in cerebral amyloid angiopathy and Alzheimer's disease

N Ziliotto, F Bernardi, F Piazza - Neurological Sciences, 2021 - Springer
Increased cerebrovascular amyloid-β (Aβ) deposition represents the main pathogenic
mechanisms characterizing Alzheimer's disease (AD) and cerebral amyloid angiopathy …

PAI-1 Regulation of p53 Expression and Senescence in Type II Alveolar Epithelial Cells

T Rana, C Jiang, S Banerjee, N Yi, JW Zmijewski, G Liu… - Cells, 2023 - mdpi.com
Cellular senescence contributes importantly to aging and aging-related diseases, including
idiopathic pulmonary fibrosis (IPF). Alveolar epithelial type II (ATII) cells are progenitors of …

[HTML][HTML] Aging, plasminogen activator inhibitor 1, brain cell senescence, and Alzheimer's Disease

CS Jiang, T Rana, LW Jin, SA Farr, JE Morley… - Aging and …, 2023 - ncbi.nlm.nih.gov
The etiology for late-onset Alzheimer's disease (LOAD), which accounts for> 95% of
Alzheimer's disease (AD) cases, is unknown. Emerging evidence suggests that cellular …

Phosphorylated tau 181 serum levels predict Alzheimer's disease in the preclinical stage

W Qin, F Li, L Jia, Q Wang, Y Li, Y Wei, Y Li… - Frontiers in Aging …, 2022 - frontiersin.org
Background There is an urgent need for cost-effective, easy-to-measure biomarkers to
identify subjects who will develop Alzheimer's disease (AD), especially at the pre …

Vascular dementia and crosstalk between the complement and coagulation systems

M Mossanen Parsi, C Duval… - Frontiers in cardiovascular …, 2021 - frontiersin.org
Vascular Dementia (VaD) is a neurocognitive disorder caused by reduced blood flow to the
brain tissue, resulting in infarction, and is the second most common type of dementia. The …

[HTML][HTML] Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease

MY Tang, FA Gorin, PJ Lein - Ageing and neurodegenerative …, 2022 - ncbi.nlm.nih.gov
Elucidating the pathogenic mechanisms of Alzheimer's disease (AD) to identify therapeutic
targets has been the focus of many decades of research. While deposition of extracellular …

The Promising Role of Selenium and Yeast in the Fight Against Protein Amyloidosis

M Kieliszek, K Sapazhenkava - Biological Trace Element Research, 2024 - Springer
In recent years, increasing attention has been paid to research on diseases related to the
deposition of misfolded proteins (amyloids) in various organs. Moreover, modern scientists …

[HTML][HTML] Screening and identification of potential peripheral blood biomarkers for Alzheimer's disease based on bioinformatics analysis

X Wang, L Wang - … Science Monitor: International Medical Journal of …, 2020 - ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is the leading cause of dementia worldwide; however,
the molecular mechanisms underlying its pathogenesis remain unclear. The present study …

Association of multiple metabolic and cardiovascular markers with the risk of cognitive decline and mortality in adults with Alzheimer's disease and AD-related …

L Liu, EJ Gracely, X Zhao, GP Gliebus… - Frontiers in aging …, 2024 - frontiersin.org
Background and objectives There is a scarcity of data stemming from large-scale
epidemiological longitudinal studies focusing on potentially preventable and controllable …